Level of In Utero Cocaine Exposure and Neonatal Ultrasound Findings

Objective.  To assess whether there is an association between the level of in utero cocaine exposure and findings on neonatal cranial ultrasound, controlling for potentially confounding variables. Study Design. In a prospective longitudinal study, three cocaine exposure groups were defined by maternal report and infant meconium assay: unexposed, heavier cocaine exposure (>75th percentile self-reported days of use or of meconium benzoylecogonine concentration) or lighter cocaine exposure (all others). Neonatal ultrasounds from 241 well, term infants were read by a single radiologist who was masked to the exposure group. Results. Infants with lighter cocaine exposure did not differ from the unexposed infants on any ultrasound findings. After controlling for infant gender, gestational age, and birth weightz scores and for maternal parity, blood pressure in labor, ethnicity, and use of cigarettes, alcohol, and marijuana during pregnancy, the more heavily cocaine-exposed infants were more likely than the unexposed infants to show subependymal hemorrhage in the caudothalamic groove (covariate adjusted odds ratio: 3.88; 95% confidence interval: 1.45, 10.35). Conclusions. This is the first study to demonstrate that ultrasound findings suggestive of vascular injury to the neonatal central nervous system are related to the level of prenatal cocaine exposure. Inconsistency in previous research in identifying an association between prenatal cocaine exposure and neonatal cranial ultrasound findings may reflect failure to consider dose effects.

[1]  H. L. Cohen,et al.  Neurosonographic findings in full‐term infants born to maternal cocaine abusers: Visualization of subependymal and periventricular cysts , 1994, Journal of clinical ultrasound : JCU.

[2]  M. Bendersky,et al.  Effects of Intraventricular Hemorrhage and Other Medical and Environmental Risks on Multiple Outcomes at Age Three Years , 1995, Journal of developmental and behavioral pediatrics : JDBP.

[3]  L. Braitman,et al.  Natal status of infants of cocaine users and control subjects: a prospective comparison. , 1995, Journal of perinatology : official journal of the California Perinatal Association.

[4]  R. Little,et al.  Perinatal brain injury in premature infants born to mothers using alcohol in pregnancy. Neonatal Brain Hemorrhage Study Team. , 1995, Pediatrics.

[5]  M. Barrett,et al.  The prevalence of illicit‐drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida , 1990, The New England journal of medicine.

[6]  E. Weinberger,et al.  Linear areas of echogenicity in the thalami and basal ganglia of neonates: an expanded association. Work in progress. , 1991, Radiology.

[7]  J. Woods,et al.  Effect of Cocaine on Uterine Blood Flow and Fetal Oxygenation , 1987, JAMA.

[8]  E. Ostrea,et al.  Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship. , 1996, Pediatrics.

[9]  F. Zuspan New concepts in the understanding of hypertensive diseases during pregnancy. An overview. , 1991, Clinics in perinatology.

[10]  C. Hobel,et al.  Prenatal and intrapartum high-risk screening. II. Risk factors reassessed. , 1979, American journal of obstetrics and gynecology.

[11]  J. Share,et al.  Ultrasonography of Infants and Children , 1991 .

[12]  I. Chasnoff,et al.  The Prevalence of Illicit-Drug or Alcohol Use during Pregnancy and Discrepancies in Mandatory Reporting in Pinellas County, Florida , 1990 .

[13]  R J Sokol,et al.  New evidence for neurobehavioral effects of in utero cocaine exposure. , 1996, The Journal of pediatrics.

[14]  B. Zuckerman,et al.  Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance. , 1996, Pediatrics.

[15]  M. Behnke,et al.  Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment. , 1998, Pediatrics.

[16]  E. Ostrea,et al.  Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. , 1992, Pediatrics.

[17]  J. Perlman,et al.  Neurologic manifestations of in utero cocaine exposure in near-term and term infants. , 1995, Pediatrics.

[18]  J. Richardson,et al.  Neurosonography of the Pre-Term Neonate , 1986, Springer New York.

[19]  J. Smeltzer,et al.  Neurosonographic abnormalities associated with maternal history of cocaine use in neonates of appropriate size for their gestational age. , 1994, AJNR. American journal of neuroradiology.

[20]  S. Dixon,et al.  Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. , 1989, The Journal of pediatrics.

[21]  B. Zuckerman,et al.  Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. , 1995, The Journal of pediatrics.

[22]  B. Haneberg,et al.  CLINICAL ASSESSMENT OF GESTATIONAL AGE IN THE NEWBORN INFANT , 1981, Acta paediatrica Scandinavica.

[23]  C. K. Hayden,et al.  Subependymal germinal matrix hemorrhage in full-term neonates. , 1985, Pediatrics.

[24]  J. Volpe Neurology of the Newborn , 1959, Major problems in clinical pediatrics.

[25]  B. Zuckerman,et al.  Maternal cocaine use: impact on child health and development. , 1996, Current problems in pediatrics.

[26]  D. Metzger,et al.  The Fifth Edition of the Addiction Severity Index. , 1992, Journal of substance abuse treatment.

[27]  M. Behnke,et al.  Incidence and description of structural brain abnormalities in newborns exposed to cocaine. , 1998, The Journal of pediatrics.

[28]  H. Bauchner,et al.  Cocaine use during pregnancy: prevalence and correlates. , 1988, Pediatrics.

[29]  C. Glasier,et al.  Cysts of the subependymal germinal matrix: sonographic demonstration with pathologic correlation. , 1983, Radiology.